Trials / Unknown
UnknownNCT04237233
Intense Monitoring Study on Tyvyt
Intense Monitoring Study on Sintilimab Injection (Tyvyt®)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study is a multi-center, prospective, non-interventional and observational study, and will collect data on the safety and efficacy of Tyvyt® in the treatment of Chinese patients with relapsed or refractory classical Hodgkin's lymphoma.
Conditions
Timeline
- Start date
- 2020-04-02
- Primary completion
- 2023-06-01
- Completion
- 2023-12-01
- First posted
- 2020-01-23
- Last updated
- 2022-09-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04237233. Inclusion in this directory is not an endorsement.